Literature DB >> 25953295

Pattern of tumor progression in liver cancer: The missing partner in trial design.

Maria Reig1,2, Jordi Bruix1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25953295     DOI: 10.1002/hep.27881

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT.

Authors:  Manuel de la Torre-Aláez; Carlota Jordán-Iborra; Andrea Casadei-Gardini; José Ignacio Bilbao; Macarena Rodriguez-Fraile; Lidia Sancho; Delia D'Avola; José Ignacio Herrero; Mercedes Iñarrairaegui; Bruno Sangro
Journal:  Cardiovasc Intervent Radiol       Date:  2020-03-12       Impact factor: 2.740

2.  Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.

Authors:  Ruwanthi Kolamunnage-Dona; Sarah Berhane; Harry Potts; Edward H Williams; James Tanner; Tobias Janowitz; Matthew Hoare; Philip Johnson
Journal:  J Hepatol       Date:  2021-05-27       Impact factor: 30.083

Review 3.  Review article: systemic treatment of hepatocellular carcinoma.

Authors:  Matthias Pinter; Markus Peck-Radosavljevic
Journal:  Aliment Pharmacol Ther       Date:  2018-07-23       Impact factor: 8.171

4.  Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score-matching cohort study.

Authors:  Wenbo Guo; Jian Gao; Wenquan Zhuang; Zhiqiang Wu; Bin Li; Song Chen
Journal:  JGH Open       Date:  2019-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.